Journal of Alzheimer's Disease

PET-based evaluation of short-term amyloid-β clearance and predictive factors in real-world Alzheimer's disease patients treated with lecanemab

By Zhen Qiao, XiaoPing Zhao, Guihong Wang, Lin Ai

Trial in peopleInterventions

The paper

Zhen Qiao, XiaoPing Zhao, Guihong Wang, Lin Ai

Capital Medical University

Journal of Alzheimer's Disease, 8 Oct 2026

doi.org/10.1177/13872877261493063 PubMed 42847291

bioRxiv4 Oct 2026
Normative brain models reveal dopamine shifts in early amyloid
medRxiv4 Oct 2026
Remote digital test flags cognitive impairment in older adults
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
Nature Communications4 Oct 2026
Brain metabolism model predicts Alzheimer tau in humans